Zum Hauptinhalt springen Zur Suche springen Zur Hauptnavigation springen
Dekorationsartikel gehören nicht zum Leistungsumfang.
Advances in Psychedelic Medicine
State-of-the-Art Therapeutic Applications
Buch von Michael Winkelman (u. a.)
Sprache: Englisch

96,60 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Lieferzeit 1-2 Wochen

Produkt Anzahl: Gib den gewünschten Wert ein oder benutze die Schaltflächen um die Anzahl zu erhöhen oder zu reduzieren.
Kategorien:
Beschreibung
Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psychological, physiological, and social problems.
More than a decade ago, the U.S. government lifted its ban on all testing of psychedelic substances. Winkelman and Sessa now provide updated scientific research and applications of these substances, now moving into approved categories of medicine. The text is an up-to-date assessment of the latest advances in the field of psychedelic medicine, covering the use of LSD, psilocybin, MDMA, ayahuasca, and other substances to augment psychotherapies for a range of disorders. It discusses medical and psychiatric concerns, clinical efficacy and safety, ethical considerations, and neuroscience findings regarding the psychedelic compounds.

Topics covered include an overview of psychiatric applications of psychedelics; treatments for addictions and depressive disorders; effects of psychedelics on inflammation and neuroplasticity; evidence for clinical applications of DMT, ayahuasca, and cannabidiol; psychedelic treatment of sociopathic disorders; microdosing psychedelics; training psychedelic therapists; and community-based harm reduction approaches to managing psychedelic crises.
Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psychological, physiological, and social problems.
More than a decade ago, the U.S. government lifted its ban on all testing of psychedelic substances. Winkelman and Sessa now provide updated scientific research and applications of these substances, now moving into approved categories of medicine. The text is an up-to-date assessment of the latest advances in the field of psychedelic medicine, covering the use of LSD, psilocybin, MDMA, ayahuasca, and other substances to augment psychotherapies for a range of disorders. It discusses medical and psychiatric concerns, clinical efficacy and safety, ethical considerations, and neuroscience findings regarding the psychedelic compounds.

Topics covered include an overview of psychiatric applications of psychedelics; treatments for addictions and depressive disorders; effects of psychedelics on inflammation and neuroplasticity; evidence for clinical applications of DMT, ayahuasca, and cannabidiol; psychedelic treatment of sociopathic disorders; microdosing psychedelics; training psychedelic therapists; and community-based harm reduction approaches to managing psychedelic crises.
Über den Autor

Michael Winkelman, PhD, is retired from the School of Human Evolution and Social Change at Arizona State University, where he served as director of the medical anthropology program.

Ben Sessa, MD, is a consultant child and adolescent psychiatrist working in adult addiction services and with PTSD in veterans.

Zusammenfassung
Provides timely information for clinicians, researchers, and advanced students of psychology, medicine, and public health, from leading clinicians, researchers, and administrators in the field
Inhaltsverzeichnis

Acknowledgments

Chapter 1 Introduction: The Psychedelic Renaissance Continues
Michael Winkelman and Ben Sessa

Part One Psychiatry
Chapter 2 Psychedelics and Psychiatry: A New Treatment Model for the 21st Century
Charles S. Grob and Gary Bravo
Chapter 3 Therapeutic Applications of 3,4-methylenedioxymethamphetamine (MDMA)
Ben Sessa
Chapter 4 Psilocybin Therapy for Major Depressive Disorder
James JH Rucker
Chapter 5 Ketamine Therapy for Treatment-Resistant Depression
L. Alison McInnes and Marc Ettensohn
Chapter 6 Evidence for the Therapeutic Effects of Ayahuasca
Dráulio Barros de Araújo

Part Two Substance Abuse
Chapter 7 Psilocybin for the Treatment of Substance Use Disorders
Ishani Rao and Greg Lydall
Chapter 8 Potential Applications of Cannabis and Cannabinoids in the Treatment of Substance Use Disorder and in Harm Reduction
José Carlos Bouso, Rafael Guimaraes dos Santos, and Jaime Hallak
Chapter 9 Psychedelic Therapy as a Complementary Treatment Approach for Alcohol Use Disorders
Peter Eischens and William Leigh Atherton

Part Three Medical Hypotheses
Chapter 10 Effects of Psychedelics on Inflammation and Immunity
Attila Szabo
Chapter 11 The Protective Role of Dimethyltryptamine against Ischemia-Reperfusion Injury
Ede Frecska, Attila Istvan Kovacs, and Attila Szabo
Chapter 12 Psychedelic Treatment of Disruptive Personality Patterns
Petr Winkler and Rita Kocárová

Part Four Treatment and Training
Chapter 13 Guidelines in Applying Psychedelic Therapies
Friederike Meckel
Chapter 14 Training Psychedelic Therapists
Janis Phelps

Part Five Societal Engagement with Psychedelics
Chapter 15 Community-Based Full-Spectrum Harm Reduction Approaches When Caring for Psychoactive- and Psychedelic-Related Problems at a Transformational Festival
Maria Carmo Carvalho, Cristiana Vale Pires, Ana Luísa Costa, Daniel Martins, Helena Valente, Inês Macedo, Paula Frango, and Raquel Lira
Chapter 16 Microdosing Psychedelics
James Fadiman and Sophia Korb
Chapter 17 Bringing Psychedelics and Entactogens into Mainstream Pharmaceuticals: A Focus on MDMA
Anne C. Wagner, Michael C. Mithoefer, and Rick Doblin

About the Editors and Contributors

Index

Details
Erscheinungsjahr: 2019
Genre: Importe
Produktart: Ratgeber
Rubrik: Gesundheit
Thema: Lexika
Medium: Buch
Inhalt: Gebunden
ISBN-13: 9781440864100
ISBN-10: 1440864101
Sprache: Englisch
Einband: Gebunden
Redaktion: Winkelman, Michael
Sessa, Ben
Hersteller: Praeger
Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de
Maße: 240 x 161 x 26 mm
Von/Mit: Michael Winkelman (u. a.)
Erscheinungsdatum: 31.03.2019
Gewicht: 0,763 kg
Artikel-ID: 115112774
Über den Autor

Michael Winkelman, PhD, is retired from the School of Human Evolution and Social Change at Arizona State University, where he served as director of the medical anthropology program.

Ben Sessa, MD, is a consultant child and adolescent psychiatrist working in adult addiction services and with PTSD in veterans.

Zusammenfassung
Provides timely information for clinicians, researchers, and advanced students of psychology, medicine, and public health, from leading clinicians, researchers, and administrators in the field
Inhaltsverzeichnis

Acknowledgments

Chapter 1 Introduction: The Psychedelic Renaissance Continues
Michael Winkelman and Ben Sessa

Part One Psychiatry
Chapter 2 Psychedelics and Psychiatry: A New Treatment Model for the 21st Century
Charles S. Grob and Gary Bravo
Chapter 3 Therapeutic Applications of 3,4-methylenedioxymethamphetamine (MDMA)
Ben Sessa
Chapter 4 Psilocybin Therapy for Major Depressive Disorder
James JH Rucker
Chapter 5 Ketamine Therapy for Treatment-Resistant Depression
L. Alison McInnes and Marc Ettensohn
Chapter 6 Evidence for the Therapeutic Effects of Ayahuasca
Dráulio Barros de Araújo

Part Two Substance Abuse
Chapter 7 Psilocybin for the Treatment of Substance Use Disorders
Ishani Rao and Greg Lydall
Chapter 8 Potential Applications of Cannabis and Cannabinoids in the Treatment of Substance Use Disorder and in Harm Reduction
José Carlos Bouso, Rafael Guimaraes dos Santos, and Jaime Hallak
Chapter 9 Psychedelic Therapy as a Complementary Treatment Approach for Alcohol Use Disorders
Peter Eischens and William Leigh Atherton

Part Three Medical Hypotheses
Chapter 10 Effects of Psychedelics on Inflammation and Immunity
Attila Szabo
Chapter 11 The Protective Role of Dimethyltryptamine against Ischemia-Reperfusion Injury
Ede Frecska, Attila Istvan Kovacs, and Attila Szabo
Chapter 12 Psychedelic Treatment of Disruptive Personality Patterns
Petr Winkler and Rita Kocárová

Part Four Treatment and Training
Chapter 13 Guidelines in Applying Psychedelic Therapies
Friederike Meckel
Chapter 14 Training Psychedelic Therapists
Janis Phelps

Part Five Societal Engagement with Psychedelics
Chapter 15 Community-Based Full-Spectrum Harm Reduction Approaches When Caring for Psychoactive- and Psychedelic-Related Problems at a Transformational Festival
Maria Carmo Carvalho, Cristiana Vale Pires, Ana Luísa Costa, Daniel Martins, Helena Valente, Inês Macedo, Paula Frango, and Raquel Lira
Chapter 16 Microdosing Psychedelics
James Fadiman and Sophia Korb
Chapter 17 Bringing Psychedelics and Entactogens into Mainstream Pharmaceuticals: A Focus on MDMA
Anne C. Wagner, Michael C. Mithoefer, and Rick Doblin

About the Editors and Contributors

Index

Details
Erscheinungsjahr: 2019
Genre: Importe
Produktart: Ratgeber
Rubrik: Gesundheit
Thema: Lexika
Medium: Buch
Inhalt: Gebunden
ISBN-13: 9781440864100
ISBN-10: 1440864101
Sprache: Englisch
Einband: Gebunden
Redaktion: Winkelman, Michael
Sessa, Ben
Hersteller: Praeger
Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de
Maße: 240 x 161 x 26 mm
Von/Mit: Michael Winkelman (u. a.)
Erscheinungsdatum: 31.03.2019
Gewicht: 0,763 kg
Artikel-ID: 115112774
Sicherheitshinweis